Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
211
-
Total shares
-
46.6M
-
Shares change
-
+2.84M
-
Total reported value, excl. options
-
$4.24B
-
Value change
-
+$267M
-
Put/Call ratio
-
0.6
-
Number of buys
-
91
-
Number of sells
-
-98
-
Price
-
$90.90
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q1 2017
222 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q1 2017.
BLUEBIRD BIO INC - COM (BLUE) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.6M shares
.
Largest 10 shareholders include FMR LLC (6.13M shares), BAILLIE GIFFORD & CO (5.2M shares), Capital Research Global Investors (4.99M shares), VANGUARD GROUP INC (3.22M shares), BlackRock Inc. (3.18M shares), WELLINGTON MANAGEMENT GROUP LLP (3.13M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.08M shares), STATE STREET CORP (1.61M shares), Capital World Investors (1.11M shares), and OppenheimerFunds, Inc. (972K shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.